Effects of beta-amyloid on cholinergic, cholinoceptive and GABAergic neurons

[1]  M. Pákáski,et al.  Vulnerability of small GABAergic neurons to human β-amyloid pentapeptide , 1998, Brain Research.

[2]  B. Penke,et al.  A putative tetrapeptide antagonist prevents beta-amyloid-induced long-term elevation of [Ca2+]i in rat astrocytes. , 1997, Biochemical and biophysical research communications.

[3]  H. Kimura,et al.  Amyloid β Toxicity Consists of a Ca2+‐Independent Early Phase and a Ca2+‐Dependent Late Phase , 1996 .

[4]  P. Puttfarcken,et al.  β-Amyloid-induced toxicity in rat hippocampal cells: In vitro evidence for the involvement of free radicals , 1995, Brain Research Bulletin.

[5]  T. Harkany,et al.  Cholinotoxic effects of β-amyloid(1–42) peptide on cortical projections of the rat nucleus basalis magnocellularis , 1995, Brain Research.

[6]  C. Cotman,et al.  Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro , 1995, Brain Research.

[7]  L. Iversen,et al.  Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Cotman,et al.  Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid , 1993, Neuroscience.

[9]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  Bruce A. Yankner,et al.  Methodological variables in the assessment of beta amyloid neurotoxicity , 1992, Neurobiology of Aging.

[11]  M. Beal,et al.  In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment , 1992, Neurobiology of Aging.

[12]  C. Geula,et al.  The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain , 1992, Neurobiology of Aging.

[13]  C. Geula,et al.  Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex , 1992, Brain Research.

[14]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[15]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[17]  T. Maeda,et al.  Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  D. Price,et al.  Glutamic acid decarboxylase-like immunoreactive neurites in senile plaques , 1985, Neuroscience Letters.

[19]  L. Iversen,et al.  Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. , 1984, Brain : a journal of neurology.

[20]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[21]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[22]  M N Rossor,et al.  A post-mortem study of the cholinergic and GABA systems in senile dementia. , 1982, Brain : a journal of neurology.

[23]  F. Wróblewski,et al.  Lactic Dehydrogenase Activity in Blood.∗ , 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.